Connect2Care: Prostate Cancer Education and Screenings for African American Men
Launched by UNIVERSITY OF OKLAHOMA · Jul 3, 2025
Trial Information
Current as of July 24, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is testing a new phone app called Connect2Care, designed to help African American men learn more about prostate cancer and the benefits and risks of early screening using a PSA test—a simple blood test that can detect prostate cancer early. Prostate cancer is the most common cancer among African American men and a leading cause of cancer-related deaths, but many men in this group don’t have enough information or don’t get screened regularly. This study aims to see if using the Connect2Care app for 30 days can improve knowledge about prostate cancer and encourage men to feel ready and confident to get screened.
Men who live in Oklahoma, identify as Black or African American, are between 45 and 69 years old, and have not had a PSA test in the past two years may be eligible to join. Participants will be randomly given either the Connect2Care app or another health app to use for 30 days. During this time, they’ll answer questions about what they’ve learned, how easy the app is to use, and how they feel about getting screened. The study will also explore if using the app helps men become more motivated and confident to take the PSA test. If successful, this app could be shared with African American men across the country to help reduce prostate cancer risks through better education and screening.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Live in Oklahoma
- • Self-identify as Black/African American
- • Self-identify as male
- • Between ages 45-69
- • Not currently diagnosed with prostate cancer
- Exclusion Criteria:
- • Participants will be excluded if they are not interested in using a phone app for 30 days
- • Has taken a PSA test or has completed PSA screening within the past two years
About University Of Oklahoma
The University of Oklahoma, a leading research institution, is dedicated to advancing healthcare through innovative clinical trials and research initiatives. With a robust network of interdisciplinary experts and state-of-the-art facilities, the university fosters an environment that promotes scientific discovery and the development of new treatments. Its commitment to patient-centered research ensures that clinical trials not only adhere to the highest ethical standards but also aim to address pressing health challenges. By collaborating with various stakeholders, including industry partners and healthcare providers, the University of Oklahoma seeks to translate research findings into tangible benefits for communities, ultimately enhancing the quality of care and improving health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Oklahoma City, Oklahoma, United States
Patients applied
Trial Officials
Jordan Neil, PhD
Principal Investigator
University of Oklahoma
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported